bpc-157 fda status or banned or approved 2026 Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the Everything You Need to Know
Description
Warfarin rats
daily, 14 days: BPC-157 demonstrated superior healing of transected Achilles tendons with improved biomechanical properties
The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance
Verify Syringe Units: Note the resulting dose volume in U-100 syringe units
